Divi's Laboratories Ltd. Share Price
6,403.50 0.00 (0.00%)Founded in 1990, Divi’s Laboratories Limited is a prominent leader in the pharmaceutical industry. They hold a dominant position in the export market. It is based in Hyderabad, India.
Business Segment
The business operations include:
- Primary Business Segment: manufacturing and sale of Active Pharmaceutical Ingredients, intermediates, custom pharmaceutical services, and nutraceutical ingredients
- Product Portfolio: includes Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam and more
In addition to generic business, the company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management.
Geographical Presence
The geographical reach spans Asia, America, Europe, and the rest of the world. The company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.
Fundamentals
Market Cap
₹1,69,993CrEPS
₹82.53Book Value/Share
₹602.55P/E Ratio (TTM)
68.57Industry P/E (TTM)
39.59P/B Ratio
11.35Long Term D/E
0.00ROE
15.35%Dividend Yield (TTM)
0.50%
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Market like performer
Very Expensive
Excellent Quality
Low Price Fluctuation
Analysts are Neutral
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Divi's Laboratories Ltd.
The share price of Divi's Laboratories Ltd. is ₹6,403.50 on NSE as of 4/3/2026, 9:11:25 am. Share prices may change frequently due to market movements.
The market capitalisation of Divi's Laboratories Ltd. is ₹1,69,993Cr as of 4/3/2026, 9:11:25 am
The current Price to Earnings (P/E) ratio of Divi's Laboratories Ltd. is 68.57 as of 4/3/2026, 9:11:25 am
The Price to Book (P/B) ratio of Divi's Laboratories Ltd. stands at 11.36 as of 4/3/2026, 9:11:25 am
Divi's Laboratories Ltd. reported an ROE of 15.35% for the last reported financial year on a consolidated account basis.
As of 4/3/2026, 9:11:25 am, Divi's Laboratories Ltd.’s shareholding pattern is: promoters hold 51.90%, FIIs hold 20.10%, DIIs hold 19.30%, and public shareholders hold 8.80%.
The 52-week high of Divi's Laboratories Ltd. is ₹6,340.00 and the 52-week low is ₹6,340.00 as of 4/3/2026, 9:11:25 am.
The earnings per share (EPS) of Divi's Laboratories Ltd. is ₹21.98 for the quarter ended Dec 2025.
The stock symbol of Divi's Laboratories Ltd. is DIVISLAB.
You can buy Divi's Laboratories Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Divi's Laboratories Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages16
Bearish Moving Averages0
5 Day
6,387.4010 Day
6,329.0020 Day
6,244.9030 Day
6,178.3050 Day
6,282.80100 Day
6,388.60150 Day
6,296.60200 Day
6,390.90Indicators
RSI (14)
57.28MACD (12, 26)
49.84MACD Signal Line (9)
19.26MFI (14)
50.41ATR (14)
162.82ADX (14)
29.59ROC (21)
5.74ROC (125)
5.10Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.